VAERS Explorer
Back to explore

Report #2900150

Received Jun 15, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
—
Recovered
Not recovered
Vaccinated
Feb 1, 2019
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS2——

Symptoms (1)

Dyspnoea

Symptom narrative

she was recently in the hospital and is feeling short of breath/winded today; This non-serious case was reported by a consumer via call center representative and described the occurrence of shortness of breath in a female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received first dose on an unknown date in 2018). In FEB-2019, the patient received the 2nd dose of Shingrix. On an unknown date, more than 2 years after receiving Shingrix, the patient experienced shortness of breath (Verbatim: she was recently in the hospital and is feeling short of breath/winded today). The outcome of the shortness of breath was not resolved. It was unknown if the reporter considered the shortness of breath to be related to Shingrix. Additional Information: GSK Receipt date: 08-JUN-2026 The patient stated that had received shot 1 of Shingrix in late 2018 and shot 2 of Shingrix in FEB-2019. The patient had gone to the pharmacy recently, where patient had been told that needed to have her shingles shot updated, but patient had declined a third dose. The patient stated that had recently been in the hospital and had felt short of breath/winded on that day. The batch number had not been provided upon follow-up with the reporter.